255 related articles for article (PubMed ID: 19234134)
1. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.
Sotgia F; Del Galdo F; Casimiro MC; Bonuccelli G; Mercier I; Whitaker-Menezes D; Daumer KM; Zhou J; Wang C; Katiyar S; Xu H; Bosco E; Quong AA; Aronow B; Witkiewicz AK; Minetti C; Frank PG; Jimenez SA; Knudsen ES; Pestell RG; Lisanti MP
Am J Pathol; 2009 Mar; 174(3):746-61. PubMed ID: 19234134
[TBL] [Abstract][Full Text] [Related]
2. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
[TBL] [Abstract][Full Text] [Related]
3. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis.
Castello-Cros R; Bonuccelli G; Molchansky A; Capozza F; Witkiewicz AK; Birbe RC; Howell A; Pestell RG; Whitaker-Menezes D; Sotgia F; Lisanti MP
Cell Cycle; 2011 Jun; 10(12):2021-34. PubMed ID: 21646868
[TBL] [Abstract][Full Text] [Related]
4. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.
Bonuccelli G; Whitaker-Menezes D; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Witkiewicz AK; Vander Heiden MG; Migneco G; Chiavarina B; Frank PG; Capozza F; Flomenberg N; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 May; 9(10):1960-71. PubMed ID: 20495363
[TBL] [Abstract][Full Text] [Related]
5. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy.
Mercier I; Casimiro MC; Wang C; Rosenberg AL; Quong J; Minkeu A; Allen KG; Danilo C; Sotgia F; Bonuccelli G; Jasmin JF; Xu H; Bosco E; Aronow B; Witkiewicz A; Pestell RG; Knudsen ES; Lisanti MP
Cancer Biol Ther; 2008 Aug; 7(8):1212-25. PubMed ID: 18458534
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
[TBL] [Abstract][Full Text] [Related]
7. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.
Williams TM; Sotgia F; Lee H; Hassan G; Di Vizio D; Bonuccelli G; Capozza F; Mercier I; Rui H; Pestell RG; Lisanti MP
Am J Pathol; 2006 Nov; 169(5):1784-801. PubMed ID: 17071600
[TBL] [Abstract][Full Text] [Related]
8. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.
Simpkins SA; Hanby AM; Holliday DL; Speirs V
J Pathol; 2012 Aug; 227(4):490-8. PubMed ID: 22488553
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.
Trimmer C; Sotgia F; Whitaker-Menezes D; Balliet RM; Eaton G; Martinez-Outschoorn UE; Pavlides S; Howell A; Iozzo RV; Pestell RG; Scherer PE; Capozza F; Lisanti MP
Cancer Biol Ther; 2011 Feb; 11(4):383-94. PubMed ID: 21150282
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
Sotgia F; Rui H; Bonuccelli G; Mercier I; Pestell RG; Lisanti MP
Cancer Res; 2006 Nov; 66(22):10647-51. PubMed ID: 17108100
[TBL] [Abstract][Full Text] [Related]
11. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
Migneco G; Whitaker-Menezes D; Chiavarina B; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Flomenberg N; Tsirigos A; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 Jun; 9(12):2412-22. PubMed ID: 20562527
[TBL] [Abstract][Full Text] [Related]
12. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.
Mercier I; Casimiro MC; Zhou J; Wang C; Plymire C; Bryant KG; Daumer KM; Sotgia F; Bonuccelli G; Witkiewicz AK; Lin J; Tran TH; Milliman J; Frank PG; Jasmin JF; Rui H; Pestell RG; Lisanti MP
Am J Pathol; 2009 Apr; 174(4):1172-90. PubMed ID: 19342371
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
14. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.
Williams TM; Lee H; Cheung MW; Cohen AW; Razani B; Iyengar P; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Jun; 279(23):24745-56. PubMed ID: 15044451
[TBL] [Abstract][Full Text] [Related]
15. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors.
Martinez-Outschoorn UE; Pavlides S; Whitaker-Menezes D; Daumer KM; Milliman JN; Chiavarina B; Migneco G; Witkiewicz AK; Martinez-Cantarin MP; Flomenberg N; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2010 Jun; 9(12):2423-33. PubMed ID: 20562526
[TBL] [Abstract][Full Text] [Related]
16. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.
Witkiewicz AK; Dasgupta A; Sotgia F; Mercier I; Pestell RG; Sabel M; Kleer CG; Brody JR; Lisanti MP
Am J Pathol; 2009 Jun; 174(6):2023-34. PubMed ID: 19411448
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 haploinsufficiency leads to partial transformation of human breast epithelial cells.
Zou W; McDaneld L; Smith LM
Anticancer Res; 2003; 23(6C):4581-6. PubMed ID: 14981899
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.
Balliet RM; Capparelli C; Guido C; Pestell TG; Martinez-Outschoorn UE; Lin Z; Whitaker-Menezes D; Chiavarina B; Pestell RG; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2011 Dec; 10(23):4065-73. PubMed ID: 22129993
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.
Martinez-Outschoorn UE; Balliet RM; Rivadeneira DB; Chiavarina B; Pavlides S; Wang C; Whitaker-Menezes D; Daumer KM; Lin Z; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Knudsen ES; Sotgia F; Lisanti MP
Cell Cycle; 2010 Aug; 9(16):3256-76. PubMed ID: 20814239
[TBL] [Abstract][Full Text] [Related]
20. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.
Pavlides S; Whitaker-Menezes D; Castello-Cros R; Flomenberg N; Witkiewicz AK; Frank PG; Casimiro MC; Wang C; Fortina P; Addya S; Pestell RG; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2009 Dec; 8(23):3984-4001. PubMed ID: 19923890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
